Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NTEC

Intec Pharma

$7.75

0.15 (1.97%)

, NVS

Novartis

$90.76

-0.79 (-0.86%)

07:06
12/06/18
12/06
07:06
12/06/18
07:06
Hot Stocks
Intec Pharma to continue development collaboration for Novartis' Accordion Pill »

Intec Pharma (NTEC)…

NTEC

Intec Pharma

$7.75

0.15 (1.97%)

NVS

Novartis

$90.76

-0.79 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
NTEC

Intec Pharma

$5.92

0.165 (2.87%)

04:55
11/19/18
11/19
04:55
11/19/18
04:55
Conference/Events
Intec Pharma management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NTEC

Intec Pharma

$5.76

(0.00%)

09:42
11/16/18
11/16
09:42
11/16/18
09:42
Conference/Events
Intec Pharma management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NTEC

Intec Pharma

$5.89

0.03 (0.51%)

07:08
11/09/18
11/09
07:08
11/09/18
07:08
Earnings
Breaking Earnings news story on Intec Pharma »

Intec Pharma reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 14

    Nov

Over a month ago
NTEC

Intec Pharma

$5.13

-0.04 (-0.77%)

07:07
10/22/18
10/22
07:07
10/22/18
07:07
Hot Stocks
Intec Pharma completes enrollment in Phase 3 trial of Parkinson's candidate »

Intec Pharma completed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTEC

Intec Pharma

$5.15

-0.06 (-1.15%)

08:32
10/05/18
10/05
08:32
10/05/18
08:32
Initiation
Intec Pharma initiated at Roth Capital »

Intec Pharma resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTEC

Intec Pharma

$5.10

-0.25 (-4.67%)

16:07
09/27/18
09/27
16:07
09/27/18
16:07
Hot Stocks
Breaking Hot Stocks news story on Intec Pharma »

Dexcel Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

KMPH

KemPharm

$4.70

(0.00%)

, CORV

Correvio

$3.90

-0.03 (-0.76%)

04:55
09/27/18
09/27
04:55
09/27/18
04:55
Conference/Events
Oppenheimer to hold a summit »

Fall Summit on Spec…

KMPH

KemPharm

$4.70

(0.00%)

CORV

Correvio

$3.90

-0.03 (-0.76%)

NTEC

Intec Pharma

$5.35

0.55 (11.46%)

SCYX

Scynexis

$1.21

-0.01 (-0.82%)

ATNM

Actinium Pharmaceuticals

$0.78

0.02 (2.63%)

CPRX

Catalyst Pharmaceuticals

$3.72

0.23 (6.59%)

REPH

Recro Pharma

$7.08

0.22 (3.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 27

    Sep

  • 01

    Oct

  • 02

    Oct

  • 27

    Nov

KMPH

KemPharm

$4.70

0.25 (5.62%)

, CORV

Correvio

$3.93

-0.08 (-2.00%)

08:11
09/26/18
09/26
08:11
09/26/18
08:11
Conference/Events
Oppenheimer to hold a summit »

Fall Summit on Spec…

KMPH

KemPharm

$4.70

0.25 (5.62%)

CORV

Correvio

$3.93

-0.08 (-2.00%)

NTEC

Intec Pharma

$4.80

0.45 (10.34%)

SCYX

Scynexis

$1.22

(0.00%)

ATNM

Actinium Pharmaceuticals

$0.76

0.0329 (4.52%)

CPRX

Catalyst Pharmaceuticals

$3.49

0.05 (1.45%)

REPH

Recro Pharma

$6.86

-0.36 (-4.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 01

    Oct

  • 02

    Oct

  • 27

    Nov

Over a quarter ago
NTEC

Intec Pharma

$4.45

0.3 (7.23%)

07:32
08/15/18
08/15
07:32
08/15/18
07:32
Earnings
Breaking Earnings news story on Intec Pharma »

Intec Pharma reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.